MIST

Milestone Pharmaceuticals (MIST)

Milestone Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:MIST

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/01/07	22:00	GlobeNewswire Inc.	Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:MIST	Milestone Pharmaceuticals Inc
2024/11/25	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:MIST	Milestone Pharmaceuticals Inc
2024/11/13	06:38	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:MIST	Milestone Pharmaceuticals Inc
2024/11/13	06:36	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:MIST	Milestone Pharmaceuticals Inc
2024/11/12	23:12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MIST	Milestone Pharmaceuticals Inc
2024/11/12	21:02	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:MIST	Milestone Pharmaceuticals Inc
2024/09/04	21:07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MIST	Milestone Pharmaceuticals Inc
2024/08/30	05:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MIST	Milestone Pharmaceuticals Inc
2024/08/30	05:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MIST	Milestone Pharmaceuticals Inc
2024/08/30	05:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MIST	Milestone Pharmaceuticals Inc
2024/08/30	05:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MIST	Milestone Pharmaceuticals Inc
2024/08/30	05:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MIST	Milestone Pharmaceuticals Inc
2024/08/30	05:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MIST	Milestone Pharmaceuticals Inc
2024/08/09	05:28	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MIST	Milestone Pharmaceuticals Inc
2024/08/09	05:13	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:MIST	Milestone Pharmaceuticals Inc
2024/07/18	05:17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MIST	Milestone Pharmaceuticals Inc
2024/07/18	05:16	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:MIST	Milestone Pharmaceuticals Inc
2024/07/18	05:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MIST	Milestone Pharmaceuticals Inc
2024/07/18	05:15	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:MIST	Milestone Pharmaceuticals Inc
2024/07/17	07:06	Edgar (US Regulatory)	Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]	NASDAQ:MIST	Milestone Pharmaceuticals Inc
2024/07/16	05:41	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:MIST	Milestone Pharmaceuticals Inc
2024/07/16	05:38	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:MIST	Milestone Pharmaceuticals Inc
2024/07/16	05:36	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:MIST	Milestone Pharmaceuticals Inc
2024/07/16	05:34	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:MIST	Milestone Pharmaceuticals Inc
2024/07/16	05:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MIST	Milestone Pharmaceuticals Inc
2024/05/29	20:09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MIST	Milestone Pharmaceuticals Inc
2024/05/22	21:00	GlobeNewswire Inc.	Milestone Pharmaceuticals Partners with Arrhythmia Alliance on SVT Awareness	NASDAQ:MIST	Milestone Pharmaceuticals Inc
2024/05/13	20:34	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MIST	Milestone Pharmaceuticals Inc
2024/05/13	19:59	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:MIST	Milestone Pharmaceuticals Inc
2024/03/04	23:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MIST	Milestone Pharmaceuticals Inc